Actively Recruiting
DiaMester Pilot RCT: E-health Lifestyle Program for Type 2 Diabetes
Led by Oslo University Hospital · Updated on 2026-01-23
99
Participants Needed
1
Research Sites
98 weeks
Total Duration
On this page
Sponsors
O
Oslo University Hospital
Lead Sponsor
U
University of Tromso
Collaborating Sponsor
AI-Summary
What this Trial Is About
This registration covers a pilot for a 3-armed parallel-group randomized controlled trial (RCT) that will evaluate the efficacy of DiaMester, a Norwegian e-health programme designed to improve self-management and induce clinically meaningful weight loss, and thereby potential remission in adults with type 2 diabetes (T2D).
CONDITIONS
Official Title
DiaMester Pilot RCT: E-health Lifestyle Program for Type 2 Diabetes
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Written informed consent
- Men and women aged 63; 18 years
- Diagnosis of type 2 diabetes for 0-6 years based on 2 recorded diagnostic-level tests (HbA1c and/or blood glucose)
- HbA1c 63; 48 mmol/mol at last routine check within 12 months if on diet alone
- HbA1c 63; 43 mmol/mol if on oral hypoglycaemic agents or GLP-1 RA treatment
- Body Mass Index (BMI) over 27 kg/m2
- Stable body weight during last 6 months with or without weight-reducing drugs
- Self-reported desire to lose weight
- Owns a smartphone
You will not qualify if you...
- Current insulin use
- More than 5% weight change or started weight-reducing drugs within last 6 months (including orlistat, bupropion-naltrekson, fenteramin-topiramat, semaglutid, tirzepatid, liraglutid, dulaglutid)
- Recent routine HbA1c 63; 108 mmol/mol
- Recent eGFR less than 30 ml/min/1.73 m2
- Known cancer
- Myocardial infarction within previous 6 months
- Severe heart failure (New York Heart Association grade 3 or equivalent)
- Pregnancy, considering pregnancy, or exclusively breastfeeding
- Substance abuse (drugs, alcohol)
- Diagnosed or suspected eating disorders
- Learning difficulties or unable to understand, speak, and read Norwegian or English
- Hospitalization for depression or current use of antipsychotic drugs
- Currently participating in another clinical research trial
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Oslo University Hospital
Oslo, Norway, 0424
Actively Recruiting
Research Team
A
Anne-Marie Aas, PhD
CONTACT
L
Lise M Østli, MSc
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here